Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple drug resistance

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 247-251

  Copitch, Justin L ^a   Whitehead, Rebekah N ^a   Webber, Mark A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Biocides; Efflux; Salmonellosis

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADPH); KANAMYCIN; NALIDIXIC ACID; PROTEIN ACRB; TETRACYCLINE; TRICLOSAN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE CARRIER; GENE EXPRESSION REGULATION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; STRAIN IDENTIFICATION; ANIMAL; ANIMAL SALMONELLOSIS; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; TRICLOSAN;

EID: 77954955213     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.012     Document Type: Article

References (15)

1. Roberts J.A., Cumberland P., Sockett P.N., Wheeler J., Rodrigues L.C., Sethi D., et al. The study of infectious intestinal disease in England: socio-economic impact. Epidemiol Infect 2003, 130:1-11.
2. St Louis M.E., Morse D.L., Potter M.E., DeMelfi T.M., Guzewich J.J., Tauxe R.V., et al. The emergence of grade A eggs as a major source of Salmonella enteritidis infections. New implications for the control of salmonellosis. JAMA 1988, 259:2103-2107.
3. Helms M., Vastrup P., Gerner-Smidt P., Mølbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002, 8:490-495.
4. Schweizer H.P. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001, 202:1-7.
5. Regös J., Hitz H.R. Investigations on the mode of action of triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol Orig A 1974, 226:390-401.
6. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
7. Heath R.J., Rubin J.R., Holland D.R., Zhang E., Snow M.E., Rock C.O. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999, 274:11110-11114.
8. Meade M.J., Waddell R.L., Callahan T.M. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 2001, 204:45-48.
9. Levy S.B. Antibacterial household products: cause for concern. Emerg Infect Dis 2001, 7:512-515.
10. Webber M.A., Randall L.P., Cooles S., Woodward M.J., Piddock L.J. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008, 62:83.
11. Andrews J.M. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001, 48:5-16.
12. Hartman P.E. Some improved methods in P22 transduction. Genetics 1974, 76:625-631.
13. Gunell M., Webber M.A., Kotilainen P., Lilly A.J., Caddick J.M., Jalava J., et al. Mechanisms of resistance in non-typhoidal Salmonella enterica exhibiting a non-classical quinolone resistance phenotype. Antimicrob Agents Chemother 2009, 53:3832-3836.
14. Randall L.P., Cooles S.W., Sayers A.R., Woodward M.J. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J Med Microbiol 2001, 50:919-924.
15. Aiello A.E., Marshall B., Levy S.B., Della-Latta P., Larson E. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 2004, 48:2973-2979.